HKSE - Delayed Quote HKD
Sinohealth Holdings Limited (2361.HK)
3.300
+0.100
+(3.12%)
At close: May 8 at 10:56:51 AM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
403,728
403,728
396,194
356,668
324,166
Cost of Revenue
170,527
170,527
172,722
197,560
131,527
Gross Profit
233,201
233,201
223,472
159,108
192,639
Operating Expense
130,315
130,315
116,471
125,687
106,306
Operating Income
102,886
102,886
107,001
33,421
86,333
Net Non Operating Interest Income Expense
25,671
25,671
26,028
6,203
-284
Pretax Income
120,148
120,148
110,741
54,474
95,529
Tax Provision
8,325
8,325
9,801
261
23,551
Net Income Common Stockholders
110,649
110,649
102,032
55,758
78,813
Diluted NI Available to Com Stockholders
110,649
110,649
102,032
55,758
78,813
Basic EPS
0.27
--
0.24
0.14
0.21
Diluted EPS
0.27
--
0.24
0.14
0.21
Basic Average Shares
410,210.244
--
426,125.312
410,666.838
373,123.325
Diluted Average Shares
410,210.244
--
426,125.312
410,666.838
373,123.325
Rent Expense Supplemental
142
142
126
66
364
Total Expenses
300,842
300,842
289,193
323,247
237,833
Net Income from Continuing & Discontinued Operation
110,649
110,649
102,032
55,758
78,813
Normalized Income
122,018.559
122,018.559
123,512.319
49,409.900
71,442.636
Interest Income
26,292
26,292
26,668
6,615
248
Interest Expense
621
621
640
412
532
Net Interest Income
25,671
25,671
26,028
6,203
-284
EBIT
120,769
120,769
111,381
54,886
96,061
EBITDA
128,813
128,813
119,947
63,615
103,413
Reconciled Cost of Revenue
170,527
170,527
172,722
197,560
131,527
Reconciled Depreciation
8,044
8,044
8,566
8,729
7,352
Net Income from Continuing Operation Net Minority Interest
110,649
110,649
102,032
55,758
78,813
Total Unusual Items Excluding Goodwill
-12,216
-12,216
-23,566
6,380
9,788
Total Unusual Items
-12,216
-12,216
-23,566
6,380
9,788
Normalized EBITDA
141,029
141,029
143,513
57,235
93,625
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-846.441
-846.441
-2,085.681
31.900
2,417.636
12/31/2021 - 7/12/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade